+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Allergic Conjunctivitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767486
  • Report
  • April 2019
  • Region: Global
  • 166 pages
  • VPA Research

FEATURED COMPANIES

  • Ajanta Pharma Ltd
  • Allergan Plc
  • NicOx SA
  • Novartis AG
  • Ora Inc
  • Sanofi
The global clinical trial report- “2019 Allergic Conjunctivitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Allergic Conjunctivitis. It presents in-depth analysis of Allergic Conjunctivitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Allergic Conjunctivitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Allergic Conjunctivitis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Allergic Conjunctivitis

The research work is prepared through extensive and continuous research on Allergic Conjunctivitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Allergic Conjunctivitis patients are identified
  • The report includes panorama of Allergic Conjunctivitis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Allergic Conjunctivitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Ajanta Pharma Ltd
  • Allergan Plc
  • NicOx SA
  • Novartis AG
  • Ora Inc
  • Sanofi
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Allergic Conjunctivitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Allergic Conjunctivitis Clinical Trials by Region
2.2.2 Average Enrollment of Allergic Conjunctivitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Allergic Conjunctivitis Treatment, 2019

3. Region wise Allergic Conjunctivitis Clinical Trials
3.1 Asia Pacific Allergic Conjunctivitis Clinical Trials by Country
3.2 Europe Allergic Conjunctivitis Clinical Trials by Country
3.3 North America Allergic Conjunctivitis Clinical Trials by Country
3.4 Middle East and Africa Allergic Conjunctivitis Clinical Trials by Country
3.5 South and Central America Allergic Conjunctivitis Clinical Trials by Country

4. Allergic Conjunctivitis Clinical Trial Trends
4.1 Start Year wise Allergic Conjunctivitis Clinical Trials
4.2 Phase wise Allergic Conjunctivitis Clinical Trials
4.3 Trial Status wise Allergic Conjunctivitis Clinical Trials
4.4 Trial Type wise Allergic Conjunctivitis Clinical Trials

5. Allergic Conjunctivitis Average Enrollment Trends
5.1 Average Enrollment in Allergic Conjunctivitis Trials by Year
5.2 Average Enrollment in Allergic Conjunctivitis Trials by Phase
5.3 Average Enrollment in Allergic Conjunctivitis Trials by Status
5.4 Average Enrollment in Allergic Conjunctivitis Trials by Type of Trial

6. Companies Participating in Allergic Conjunctivitis Clinical Trials
6.1 Allergic Conjunctivitis Trials by Sponsor Type
6.2 Allergic Conjunctivitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Allergic Conjunctivitis Trials- Phase 1
7.2 Allergic Conjunctivitis Trials- Phase 2
7.3 Allergic Conjunctivitis Trials- Phase 3
7.4 Allergic Conjunctivitis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Allergic Conjunctivitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Figure 9: Allergic Conjunctivitis Clinical Trials by Phase
Figure 10: Allergic Conjunctivitis Clinical Trials by Trial Status
Figure 11: Allergic Conjunctivitis Clinical Trials by Type
Figure 12: Allergic Conjunctivitis Clinical Trials by Sponsor Type
Figure 13: Allergic Conjunctivitis Clinical Trials by Leading Sponsors
Figure 14: Allergic Conjunctivitis Average Enrollment by Phase
Figure 15: Allergic Conjunctivitis Average Enrollment by Trial Status
Figure 16: Allergic Conjunctivitis Average Enrollment by Type
Figure 17: Allergic Conjunctivitis- Average Enrolment by Type of Sponsors
Figure 18: Allergic Conjunctivitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Allergic Conjunctivitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Table 7: North America - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Allergic Conjunctivitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Allergic Conjunctivitis Average Enrollment by Phase
Table 15: Allergic Conjunctivitis Average Enrollment by Trial Status
Table 16: Allergic Conjunctivitis Average Enrollment by Type
Table 17: Allergic Conjunctivitis- Average Enrolment by Type of Sponsors
Table 18: Allergic Conjunctivitis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • Ajanta Pharma Ltd
  • Allergan Plc
  • Bausch Health Companies Inc
  • Johnson & Johnson Vision Care Inc
  • NicOx SA
  • Novartis AG
  • Ora Inc
  • Sanofi
  • Santen Pharmaceutical Co Ltd
  • UCB SA
Note: Product cover images may vary from those shown
Adroll
adroll